Agenda
Global Healthcare Conference
Grand Hyatt New York, 109 East 42nd Street
Monday, May 22
Meeting Room
Breakout Room
Ballroom III
Broadway
Ballroom II
Alvin-Carnegie
Ballroom IV
Julliard
Ballroom V
Uris
Breakout session to follow immediately after presentation, unless otherwise noted. Each session will last 30 minutes.
7:15 a.m.
7:45 a.m.
Registration and continental breakfast
8:00 a.m.
AbbVie Inc.* (F)
Richard Gonzalez, Chairman of the Board &
Chief Executive Officer
William Chase EVP & Chief Financial Officer
Scott Brun, Vice President, AbbVie Ventures
Tenet Healthcare
Trevor Fetter, Chairman & Chief Executive
Officer
Daniel Cancelmi, Chief Financial Officer
Teladoc* (F)
Jason Gorevic, Chief Executive Officer
Mark Hirschhorn, Chief Operating Officer &
Chief Financial Officer
Editas Medicine
Katrine Bosley, Chief Executive Officer
Andrew Hack, Chief Financial Officer
Vifor Pharma
Colin Bond, Chief Financial Officer
Angio Dynamics
Michael Greiner, Chief Financial Officer
XOMA LTD
Jim Neal, Chief Executive Officer
Tom Burns, Chief Financial Officer
9:00 a.m.
Valeant Pharmaceuticals International (F)
Joseph Papa, Chief Executive Officer
Novo-Nordisk A/S
Anders Mikkelsen, Investor Relations Manager
Meridian Bioscience
Jack Kraeutler, Chairman & Chief Executive
Officer
Richard Eberly, President & Chief Operating
Officer
Cerner Corp
Marc Naughton, EVP & Chief Financial
Officer
9:30 a.m.
Merck KGaA
Udit Batra, Member of the Executive Board &
Chief Executive Officer, Life Sciences
The Providence Service Corp
James Lindstrom, Chief Executive Officer
MDLive
Scott Decker, Chief Executive Officer
Randy Parker, Founder & Chief Business
Development Officer
10:00 a.m.
Bristol-Myers Squibb Co.* (F)
Murdo Gordon, Chief Commercial Officer
Ra Pharmaceuticals
Doug Treco, President & Chief Executive Officer
David Lubner, EVP & Chief Financial Officer
Civitas Solutions
Chris Kozakis, Treasurer
Dwight Robson, Chief Public Strategy &
Marketing Officer
10:30 a.m.
Aetna
Mark Bertolini, Chairman & Chief Executive
Officer
11:00 a.m.
Owens & Minor, Inc.
Randy Meier, EVP, Chief Financial Officer
& President International
Chuck Graves, Director, Finance & Investor
Relations
Incyte Corp.*
Herve Hoppenot, Chairman, President &
Chief Executive Officer
Integra Lifesciences Holdings Corp.
Dan Reuvers, President, Specialty Surgical
Solutions
Angela Steinway, Global Head of Strategic
Initiatives & Investor Relations
Hill-Rom
John Greisch, President & CEO
Steve Strobel, SVP, Finance & Chief Financial
Officer
Mary Kay Ladone, VP, Investor Relations
Cambrex Corporation
Steven Klosk, President & Chief Executive
Officer
Tom Vadaketh, EVP & Chief Financial Officer
Invitae
Sean George, Chief Executive Officer
8:30 a.m.
11:30 a.m.
Welcome remarks
Syndax Pharmaceuticals Inc.
Briggs Morrison, Chief Executive Officer &
Director
Myovant Sciences Ltd
Lynn Seely, President & Chief Executive Officer
Frank Karbe, Chief Financial Officer
Acceleron Pharma
Habib Dable, President & Chief Executive
Officer
Teleflex Inc.
Liam Kelly, President & Chief Operating Officer
Jake Elguicze, Treasurer & VP, Investor
Relations
Audentes Therapeutics
Matt Patterson, President & Chief Executive
Officer
Tom Soloway, SVP & Chief Financial Officer
Intarcia
Owen Hughes, Chief Business Officer
11:45 a.m.
12:00 p.m.
Lunch - Boxed lunches will be available in the Ballroom foyer
1:00 p.m.
Henry Schein Inc. (F)
Stanley Bergman, Chairman & Chief Executive
Officer
Amicus Therapeutics
Chip Baird, Chief Financial Officer
Atlas Genetics
John Clarkson, Chief Executive Officer
Bob Johnston, Chief Financial Officer
miRagen Therapeutics, Inc.
William Marshall, President & Chief Executive
Officer
1:30 p.m.
Centene Corporation
Ed Kroll, SVP, Finance & Investor Relations
Erica Silver, Director, Investor Relations
Nektar Therapeutics
Jonathan Zalevsky, SVP, Biology & Preclinical
Development, Research Biology
Merit Medical Systems
Fred Lampropoulos, Chairman & Chief
Executive Officer
Seres Therapeutics
Eric D. Schaff, Executive Vice President &
Chief Financial Officer
2:00 p.m.
Community Health Systems
Tom Aaron, Executive Vice President & Chief
Financial Officer
Morphosys
Simon Moroney, Chief Executive Officer
Mainstay Medical
Peter Crosby, Chief Executive Officer
2:30 p.m.
Mylan NV (F)
Ken Parks, Chief Financial Officer
Globus Medical Inc.
Dan Scavilla, EVP & Chief Financial Officer
CureVac
Pierre Kemula, Chief Financial Officer
3:00 p.m.
Universal Health Services, Inc. (F)
Steve Filton, Chief Financial Officer
Basilea Pharmaceutica International Ltd.
Ronald Scott, Chief Executive Officer
RaNA Therapeutics
Ronald Renaud, Chief Executive Officer
Thomas McCauley, Chief Financial Officer
4:15 p.m.
TAVR Panel
5:15 p.m.
Conference concludes
Keynote Speaker
Doug Holtz-Eakin, President, American Action Forum
Pathway Genomics
Kamal Adwani, Chief Financial Officer
Dr. Michael Nova, Chief Innovation Officer
(F) = Fireside Chat
* = No Breakout Session
To access the audio webcast:
Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of Global Healthcare Conference. Please note: Only companies who have chosen to webcast will be listed.
© UBS 2017. All rights reserved. All pictures or images presented herein, are for illustrative purposes only. No relationship, association, sponsorship, or endorsement is suggested or implied between UBS and any landmarks or properties, or with their respective owners, organizations, management, sponsors, investors or
patrons.
Agenda
Global Healthcare Conference
Grand Hyatt New York, 109 East 42nd Street
Tuesday, May 23
Meeting Room
Breakout Room
Ballroom III
Broadway
Ballroom II
Alvin-Carnegie
Ballroom IV
Julliard
Ballroom V
Uris
Breakout session to follow immediately after presentation, unless otherwise noted. Each session will last 30 minutes.
7:15 a.m.
8:00 a.m.
Registration and continental breakfast
HealthSouth Corp (F)
Mark Tarr, Chief Executive Officer
Endo International plc
Paul Campanelli, President & Chief Executive
Officer
8:30 a.m.
Wright Medical Group N.V. (F)
Lance Berry, Chief Financial Officer
Julie Tracy, Senior Vice President &
Chief Communications Officer
Baxter International (F)
Jay Saccaro, Chief Financial Officer
Prothena Corp PLC*
Gene Kinney, President & Chief Executive
Officer
Tran Nguyen, Chief Financial Officer
Momenta Pharmaceuticals
Scott Storer, Chief Financial Officer
Takeda Pharmaceutical Co Ltd.
James Kehoe, Chief Financial Officer
Andrew Plump, Chief Medical and
Scientific Officer
Johnson & Johnson (F)
Dominic Caruso, EVP & Chief
Financial Officer
Joseph Wolk, VP, Investor Relations
Service Corp International
Eric Tanzberger, SVP & Chief Financial Officer
Debbie Young, Director, Investor Relations
10:30 a.m.
Walgreens Boots Alliance Inc (F)
Stefano Pessina, Executive Vice Chairman
& Chief Executive Officer
11:00 a.m.
Eli Lilly (F)
Derica Rice, Executive Vice President,
Global Services & Chief Financial Officer
Senior Housing Properties Trust
David Hegarty, President & Chief Operating
Officer
Rick Siedel, Chief Financial Officer
Vertex Pharmaceuticals*
Ian Smith, Chief Operating Officer
& Chief Financial Officer
11:30 a.m.
Hologic
Robert McMahon, Chief Financial
Officer
Mednax Inc.
Charlie Lynch, VP, Investor Relations
and Strategy
11:45 a.m.
12:00 p.m.
Lunch - Boxed lunches will be available in the Ballroom foyer
9:00 a.m.
9:30 a.m.
10:00 a.m.
1:00 p.m.
Galapagos NV
Elizabeth Goodwin, VP, Investor Relations &
Corporate Communications
AC Immune
Andrea Pfeifer, Chief Executive Officer
OraSure Technologies
Doug Michels, President & CEO
Esperion Therapeutics Inc. (F)
AAC Holdings
Tim Mayleben, President & Chief Executive Officer Michael Cartwright, Chairman & Chief Executive
Officer
Kirk Manz, Chief Financial Officer
InTouch Health
TCR2 Therapeutics
Joseph DeVivo, Chief Executive Officer
Garry Menzel, Chief Executive Officer
Depomed (F)
Arthur Higgins, President & Chief Executive
Officer
Augie Moretti, SVP & Chief Financial
Officer
Healthcare Services Group
Theordore Wahl, Chief Executive Officer
Matthew McKee, SVP, Strategy
RCCH HealthCare Partners
Martin Rash, Chairman & Chief Executive Officer
Mike Browder, EVP & Chief Financial Officer
Selecta Biosciences
Werner Cautreels, Chairman,
President & Chief Executive Officer
Health Insurance Innovations
Gavin Southwell, Chief Executive Officer
& President
Michael Hershberger, Chief Financial
Officer
Zymeworks
Ali Tehrani, President & Chief Executive Officer
Welltok
Jeff Margolis, Chairman & Chief Executive
Officer
Moderator: Jim Forbes, Vice Chairman UBS Group, Americas; Managing Director, Healthcare Investment Banking
Robert DiGia, Managing Director, Global Head of Healthcare Investment Banking
Marc-Anthony Hourihan, Managing Director, Co-Head of Americas M&A
Ridwan Obaray, Managing Director, Healthcare Investment Banking
Holly Sheffield, Managing Director, Healthcare Investment Banking
Jazz Pharmaceuticals
Aeglea BioTherapeutics
Quorum Health Corp
Russ Cox, Chief Operating Officer
David Lowe, Chief Executive Officer
Michael Culotta, EVP & Chief
Charles York, Chief Financial Officer
Financial Officer
Celgene Corporation* (F)
Michael Pehl, President, Global
Hematology & Oncology
Qiagen NV
Roland Sackers, Chief Financial
Officer
CRISPR Therapeutics
Rodger Novak, Chief Executive Officer
Samarth Kulkarni, Chief Business Officer
2:00 p.m.
Boston Scientific Corporation (F)
Susan Lisa, VP, Investor Relations
West Pharmaceutical Services
William Federici, Sr. VP & Chief Financial Officer
2:30 p.m.
Quest Diagnostics Incorporated
Mark Guinan, EVP & Chief Financial
Officer
Shawn Bevec, Executive Director,
Investor Relations
Allscripts Healthcare Solutions Inc (F)
Seth Frank, VP, Finance
Leigh Burchell, VP, Government Affairs
Mallinckrodt PLC
Mark Trudeau, President & Chief Executive
Officer
Steven Romano, EVP & Chief Scientific
Officer
Intercept Pharmaceuticals (F)
Sandip Kapadia, Chief Financial
Officer
3:30 p.m.
4:00 p.m.
4:30 p.m.
Quotient
Paul Cowan, Chairman & Chief Executive Officer
Keynote panel: Healthcare M&A Trends in 2017
UBS
1:30 p.m.
3:00 p.m.
Helsinn Healthcare SA
William Mann, President & Chief Executive Officer
LifePoint Health (F)
Bill Carpenter, Chairman & Chief Executive
Officer
Mike Coggin, Chief Financial Officer
Business sessions conclude
Neos Therapeutics
Vipin Garg, Chief Executive Officer
Richard Eisenstadt, Chief Financial
Officer
uniQure N.V.
Matthew Kapusta, Chief Executive
Officer
Tabula Rasa Healthcare, Inc.
Brian Adams, Chief Financial Officer
Obalon Therapeutics Inc. (F)
Andy Rasdal, Chief Executive Officer
William Plovanic, Chief Financial Officer
Concert Pharma
Roger Tung, President & Chief Executive
Officer
Ryan Daws, Chief Financial Officer
BioQ Pharma Incorporated
Joshua Kriesel, President & Chief Executive Officer
Ronald Pauli, Chief Financial Officer
Abeona Therapeutics
Christine Berni, Vice President, Investor
Relations
Curant Health
Patrick Dunham, Chief Executive Officer
Marc O' Connor, Principal, Chief Operating
Officer
Apogenix
Thomas Hoeger, Chief Executive Officer
Breakout sessions conclude
(F) = Fireside Chat
* = No Breakout Session
To access the audio webcast:
Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of Global Healthcare Conference. Please note: Only companies who have chosen to webcast will be listed.
© UBS 2017. All rights reserved. All pictures or images presented herein, are for illustrative purposes only. No relationship, association, sponsorship, or endorsement is suggested or implied between UBS and any landmarks or properties, or with their respective owners, organizations, management, sponsors, investors or
patrons.
Agenda
Global Healthcare Conference
Grand Hyatt New York, 109 East 42nd Street
Wednesday, May 24
Meeting Room
Breakout Room
Ballroom III
Broadway
Ballroom II
Alvin-Carnegie
Ballroom IV
Julliard
Ballroom V
Uris
Breakout session to follow immediately after presentation, unless otherwise noted. Each session will last 30 minutes.
7:15 a.m.
Registration and continental breakfast
8:00 a.m.
Roche Holdings
Daniel O'Day, Chief Executive Officer
ICON PLC
Brendan Brennan, Chief Financial Officer
Jonathan Curtain, Vice President, Corporate
Finance and Investor Relations
Anthem Inc. (F)
Joseph Swedish, Chairman, President & CEO
John Gallina, EVP & Chief Financial Officer
9:00 a.m.
Perrigo
John Hendrickson, Chief Executive Officer
AveXis
Sean Nolan, President & Chief Executive Officer
K2M Group Holdings Inc. (F)
Eric Major, Chief Executive Officer
Greg Cole, Chief Financial Officer
9:30 a.m.
HCA Holdings (F)
Sam Hazen, President & Chief Operating
Officer
Bill Rutherford, EVP & Chief Financial Officer
Jonathan Perlin, President, Clinical Service
& Chief Marketing Officer
Vic Campbell, Senior Vice President
Mark Kimbrough, Vice President, Investor
Neon Therapeutics
Daniella Beckman, Chief Financial Officer
Alexandria RE Equities
Joel Marcus, Chairman, Chief Executive Officer
& Founder
Alnylam
Barry Greene, President
Spectranetics
Michaella Gallina, Director, Investor Relations
Millendo Therapeutics, Inc.*
Julia Owens, President & Chief Executive Officer
Christopher Seiter, Chief Financial Officer
Impax Laboratories
Paul Bisaro, President & Chief Executive Officer
BeiGene
John Oyler, Chief Executive Officer
Howard Liang, Chief Financial Officer &
Chief Strategy Officer
Cross Country Healthcare
William Grubbs, President & Chief Executive
Officer
10:00 a.m.
10:30 a.m.
Acadia Healthcare Co Inc.
Joey Jacobs, Chairman & Chief Executive Officer
Brent Turner, President
11:00 a.m.
NovoCure Ltd.
William Doyle, Executive Chairman
11:30 a.m.
AMN Healthcare Services
Brian Scott, Chief Financial Officer
11:45 a.m
12:00 p.m
12:30 p.m
12:00 - 5:00 p.m.
Lunch - Boxed lunches will be available in the Ballroom foyer
5:00 p.m.
Conference concludes
Twist Bioscience
Emily Leproust, Chief Executive Officer
Solange Glaize, Chief Financial Officer
Head of Global Research & Development
Probiodrug AG
Konrad Glund, Chief Executive Officer
8:30 a.m.
Relations
CVS Health Corp (F)
Larry Merlo, President & Chief Executive Officer
Ablynx
Edwin Moses, Chief Executive Officer
Hookipa Biotech AG
Jörn Aldag, Chief Executive Officer
Igor Matushansky, Chief Marketing Officer,
Sera Prognostics
Greg Critchfield, Chief Executive Officer
Business Sessions Conclude
Breakout Sessions Conclude
One-on-one and group meetings
(F) = Fireside Chat
* = No Breakout Session
To access the audio webcast:
Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of Global Healthcare Conference. Please note: Only companies who have chosen to webcast will be listed.
© UBS 2017. All rights reserved. All pictures or images presented herein, are for illustrative purposes only. No relationship, association, sponsorship, or endorsement is suggested or implied between UBS and any landmarks or properties, or with their respective owners, organizations, management, sponsors, investors or
patrons.
Agenda
Global Healthcare Conference
Grand Hyatt New York, 109 East 42nd Street
One-on-one and Group Meetings Only
Company Name
Alkermes
Cardinal Health
Cigna
Daiichi Sankyo
GlaxoSmithKline
GW Pharmaceuticals
InflaRx
Kindred Healthcare
Merck
PAREXEL International
Pfizer
Philips
Sosei Group
To access the audio webcast:
Go to www.ibb.ubs.com/Conferences. Look for the webcast link to the right of Global Healthcare Conference. Please note: Only companies who have chosen to webcast will be listed.
© UBS 2016. All rights reserved. All pictures or images presented herein, are for illustrative purposes only. No relationship, association, sponsorship, or endorsement is suggested or implied between UBS and any landmarks or properties, or with their respective owners, organizations, management, sponsors, investors or
patrons.